Your browser doesn't support javascript.
COVID-19 during Early Phase of Autologous Stem Cell Transplantation.
Milczarek, Slawomir; Baumert, Bartlomiej; Sobus, Anna; Wilk-Milczarek, Ewa; Sommerfeld, Krzysztof; Osekowska, Bogumila; Borowiecka, Ewa; Paczkowska, Edyta; Lanocha, Aleksandra; Poncyliusz, Wojciech; Jarosz, Konrad; Machalinski, Boguslaw.
  • Milczarek S; Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Baumert B; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Sobus A; Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Wilk-Milczarek E; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Sommerfeld K; Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Osekowska B; Department of General and Dental Radiology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Borowiecka E; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Paczkowska E; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Lanocha A; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Poncyliusz W; Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Jarosz K; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Machalinski B; Department of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.
Medicina (Kaunas) ; 57(7)2021 Jul 17.
Article in English | MEDLINE | ID: covidwho-1314694
ABSTRACT
We present one of few cases of COVID-19 occurrence during the early phase of autologous hematopoietic stem cell transplantation. We observed an interesting correlation between the patient's rapid clinical deterioration and myeloid reconstitution that cannot be assigned to engraftment syndrome. Our report emphasizes the need to investigate whether timely steroid therapy upon neutrophil engraftment in the setting of COVID-19 could limit the extent of lung injury and prevent ARDS. Furthermore, we discuss a significant issue of possible prolonged incubation of the virus in heavily pretreated hematological patients.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Type of study: Case report / Prognostic study Limits: Humans Language: English Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Medicina57070724

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Type of study: Case report / Prognostic study Limits: Humans Language: English Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Medicina57070724